J0134
J0134 – Injection, acetaminophen (fresenius kabi) not therapeutically equivalent · NDC Crosswalk & Billing Units
HCPCS Level II J-code · Medicare Part B drug billing
J-code
● 1 NDC crosswalked per 10 MG $0.050/unit ASP+6%
📋 J0134 summary
J0134 is a HCPCS Level II J-code used to bill acetaminophen (fresenius kabi) not therapeutically equivalent to j0131, 10 mg, billed per 10 MG. The number of billing units to report depends on the dose administered and the NDC/package billed — use the calculator below.
Brand names associated with J0134: Acetaminophen(J0134)
Code J0134
Billing unit 10 MG Payment limit $0.050/unit NDC-Crosswalk 1
Quarter Q3 2026
RxCUI Atlas Trace the drug concept →
⚠ An NDC↔HCPCS crosswalk and a published payment limit do not guarantee payer coverage or payment. Always verify the current payer policy and claim format before billing.
🗂️ Key billing facts
HCPCS codeJ0134
DescriptorInjection, acetaminophen (fresenius kabi) not therapeutically equivalent to j0131, 10 mg
Billing unit10 MG
Payment limit / unit$0.050
Est. ASP / unit$0.047 est.
Mapped NDCs1
Data periodQ3 2026
Last updated2026-08-20
💊 About Acetaminophen DRUG GUIDE
Acetaminophen temporarily relieves minor aches and pains caused by headaches, the common cold, backaches, muscle aches, toothaches, minor arthritis pain, and premenstrual or menstrual cramps.
It also temporarily reduces fever.These uses apply across oral tablet, suspension, and oral liquid products.
The intravenous (IV) injection form is used in clinical settings to treat acute pain and fever, including in pediatric patients 2 years and older.
Clinical overview from our editorial drug guide for Acetaminophen. For billing reference, see the sections above.
🧾 Billing & reimbursement HCPCS · CMS · EFF. Q3 2026
📅 Payment limits effective Q3 2026 — from the CMS Medicare Part B Payment Limit File (revised quarterly).
Medicare payment limit / unit
$0.050
Est. ASP / unit
$0.047 est.
Est. after 2% sequester
$0.049
HCPCS dosage
10 MG
The CMS payment limit is the Medicare Part B drug allowance (ASP + 6%, statutory). After the 2% federal sequester the effective payment is ≈ ASP + 4.3%; estimated ASP = payment limit ÷ 1.06. Source: CMS Medicare Part B Payment Limit File (quarterly), Q3 2026.
Full HCPCS code details (official CMS record)
Long descriptionInjection, acetaminophen (fresenius kabi) not therapeutically equivalent to j0131, 10 mg
CoverageC — Carrier/MAC judgment
Pricing indicator51 — Drug — priced under the ASP methodology
Type of service1 — Medical care
BETOS-2O1E
ASC payment groupYY
Action codeP — Payment change
Effective date2024-01-01
Date added2023-01-01
Source: CMS HCPCS Level II code file (imported via admin).
🧮 Dosing & billing-units calculator HCPCS UNITS
One billing unit of J0134 = 10 mg. Enter a regimen to convert dose → billing units and project a full course.
Billing units = dose ÷ HCPCS unit size. Most payers require whole units — round per the payer's policy. “Est. Medicare pay” uses the current payment limit. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (JZ when none is discarded) where allowed. Always verify payer-specific rounding before billing.
🔁 NDCs that bill under J0134 WITH EST. MEDICARE PAY
1 NDC map to J0134. Bill units = how many HCPCS units one package represents. Est. pay / pkg = payment limit ($0.050/unit) × that package's bill units.
| NDC (11-digit) | Drug | Labeler | Package | Strength | Bill units | Est. pay / pkg | NADAC / unit | Status | Source |
|---|---|---|---|---|---|---|---|---|---|
| 63323-0434-00 | Acetaminophen 10 mg/mL INJECTION | Fresenius | 20 BAG in 1 CASE (63323-434-00) / 100 mL... | 10 mg/mL | 2,000 | $100.00 | — | ● Active | CMS ASP |
NDC→HCPCS mappings come from the CMS ASP NDC-HCPCS crosswalk; additional DME MAC / DMEPOS mappings come from PDAC and are labeled separately. NADAC from CMS (weekly). “Status” reflects the product's marketing / obsolete flag in the NDC directory. Presence or absence here does not determine Medicare coverage. Linked NDCs open the full product page.
📊 Medicare utilization & spend CMS · PART B · 2026 (Q1)
Period
Total Part B spend
$34.54
Claims
12
Beneficiaries
—
Spend / beneficiary
—
Spend / claim
$2.88
Trend by period
Where J0134 ranks among Part B drugs · 2026 (Q1) · neighbors ±5
Total spending — #819 of 824
#814
CEFAZOLIN SODIUM(J06... J0688
$69.34
#815
HEPARIN SODIUM J1643
$64.49
#816
DIMENHYDRINATE J1240
$52.85
#817
BREVIBLOC* J1805
$44.41
#818
DOXERCALCIFEROL* J1270
$40.18
#819
ACETAMINOPHEN(J0134) J0134
$34.54
#820
ONDANSETRON HCL(Q016... Q0162
$34.36
#821
HYDROXOCOBALAMIN J3425
$20.01
#822
ACETADOTE* J0132
$8.67
#823
DAPTOMYCIN-0.9% NACL J0874
$1.38
#824
CHLOROPROCAINE HCL* J2401
$1.04
Total claims — #816 of 824
#811
ONCASPAR J9266
14
#812
BICILLIN C-R J0558
13
#813
ZINPLAVA J0565
13
#814
PELLOGRAFT, PER SQ C... Q4320
13
#815
RETACRIT(Q5105) Q5105
13
#816
ACETAMINOPHEN(J0134) J0134
12
#817
POSACONAZOLE J1837
12
#818
HYMPAVZI PEN J7172
12
#819
DERMACYTE AMN MEM AL... Q4248
12
#820
ORION, PER SQ CM** Q4276
12
#821
DERMACYTE AC MATRX P... Q4343
12
Top Medicare Part B drugs by the selected metric. Click any drug to open its J-code page. Source: CMS Medicare Quarterly Part B Spending by Drug.
Full breakdown by period (2)
| Period | Total spend | Beneficiaries | Claims | $/beneficiary | $/claim |
|---|---|---|---|---|---|
| 2026 (Q1) | $34.54 | — | 12 | — | $2.88 |
| 2025 (Q1-Q4) | $54.02 | — | 14 | — | $3.86 |
Provider-administered (Part B) spend, calculated for the whole HCPCS code (CMS does not publish Medicare spend per individual NDC). Self-administered use is covered under Part D instead. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part B Spending by Drug (data.cms.gov), updated quarterly.
📈 Medicare Part B claims detail CMS PSPS · 2024
Calendar-year 2024 Medicare Part B fee-for-service activity for this HCPCS code, summed across all carriers, localities and specialties (CMS Physician/Supplier Procedure Summary). A “service” is one billed line/unit — not one claim — so counts run higher than claim counts.
Allowed charges
$54.78
Medicare paid
$38.58
Submitted services
55,410
Denial rate
98.0%
Allowed / service
$0.05
Submitted charges
$29K
Source: CMS Physician/Supplier Procedure Summary (PSPS), CY2024 — Medicare Part B carrier + DME fee-for-service claims (excludes Medicare Advantage). Figures are for the whole HCPCS code, which may cover uses beyond this drug. ⚠ CMS hides any figure covering fewer than 11 patients (a privacy rule), so totals — especially denials and low-volume codes — run a little low.
🗺️ Where J0134 is utilized
⏳
The geographic utilization map is building for this code — it aggregates millions of CMS Part B claim lines, then caches the result. Refresh in a moment; if it doesn’t appear, this code may have no reportable Part B utilization.
🗃️ Data sources & freshness
Every figure on this page is computed from public datasets. Here's what each section draws on and how current it is.
HCPCS code & descriptor
CMS HCPCS Level II code file
Loaded
Payment limit & billing unit
CMS Medicare Part B ASP Pricing File (quarterly)
Q3 2026 · as of 2026-08-20
NDC ↔ HCPCS crosswalk
CMS ASP NDC-HCPCS crosswalk
1 NDC mapped
NADAC acquisition cost
CMS National Average Drug Acquisition Cost (weekly)
Not available for mapped NDCs
Utilization & spend
CMS Part B Spending by Drug · PSPS · Physician & Other Practitioners
Latest data year 2026
Figures are estimates for reference and may lag the source files. Always verify against the current CMS files and your payer's policy before submitting claims.
⚠️ Practical billing caveats
- A crosswalk is not coverage. An NDC mapping or a published payment limit does not guarantee a payer will cover or pay this code. Check the specific plan's policy.
- Units ≠ milligrams. Bill the number of HCPCS units (dose ÷ the code's unit size), not the milligram dose. Use the calculator above.
- Discarded drug. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (and JZ when nothing is discarded) where the payer allows.
- Rounding & partial units. Many payers require whole units; round per the payer's policy, not automatically up.
- The code can cover more than this drug. Some HCPCS codes span multiple products or strengths — confirm the exact code for the product administered.
- Figures lag. ASP limits change quarterly and utilization data are released with a delay. Verify against the current CMS files before billing.
❓ J0134 billing FAQ
What is HCPCS code J0134?
J0134 is a HCPCS Level II J-code used to bill Injection, acetaminophen (fresenius kabi) not therapeutically equivalent to j0131, 10 mg under Medicare Part B and most medical (not pharmacy) benefits.
What is the billing unit for J0134?
One unit of J0134 represents 10 MG. Report the number of units equal to the dose administered divided by 10 MG.
How many units of J0134 should I bill?
Divide the dose administered by the code's unit size (10 MG) to get the number of billing units, then round per your payer's policy. The calculator on this page converts a dose into billing units and projects a full course.
How much does Medicare pay for J0134?
The Medicare Part B payment limit is $0.050 per unit (Q3 2026), based on ASP + 6%. After the 2% sequester the effective payment is about $0.049 per unit. Payment limits are revised quarterly.
Which NDCs bill under J0134?
1 NDC currently map to J0134 in the CMS ASP NDC-HCPCS crosswalk. See the NDC crosswalk table above for each product, package, billing units and estimated reimbursement.
Does a crosswalk mean J0134 is covered?
No. An NDC-to-HCPCS crosswalk and a published payment limit do not guarantee coverage or payment. Coverage depends on the payer, the diagnosis and the site of care — always verify the current policy before billing.
For professional billing reference only — verify against the current CMS files before submitting claims.